Why is Boston Bio falling/rising?

As of 18-Aug, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.82, which reflects a decrease of 0.08 or 1.01%. The stock has underperformed its sector today by 1.04% and has been on a consecutive downward trend for the last two days, resulting in a total decline of 2.13%. Although the stock has shown a positive return of 1.43% over the past week and 7.57% over the past month, it is currently trading lower than its 5-day, 100-day, and 200-day moving averages, indicating a potential weakness in momentum. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 99.66% against the 5-day average, which suggests reduced interest from investors.
In the broader market context, the stock's recent performance can be compared to the Sensex, which has gained 0.83% over the past week and has declined by 0.59% over the past month. While Boston Bio's short-term returns are better than the benchmark for the week and month, the overall trend of falling prices and reduced trading volume indicates a challenging environment for the stock. The lack of available positive or negative factors further complicates the assessment of its recent movement, leaving investors with limited insights into potential catalysts for recovery.